Opinion

DoH 'wastes' millions on access survey

03-Aug-07

So have you had a stampede of patients either to or from your front door following the release of the DoH's long-awaited and much-hyped access survey?

These figures were going to cause patients to flock to walk-in centres as if they were selling the latest Kate Moss hotpants, because their old surgeries were providing such a dismal service. Instead, they reveal that patients are pretty happy with their GPs and surgery opening times.

If there was any doubt that the Hewitt-era DoH was spinning against GPs, these results offer the proof. Back in May, officials warned PCTs to brace themselves for a mass migration of patients 'wanting to change registration to practices with higher satisfaction rates'.

The clear implication was that the majority of patients were dissatisfied with GPs and opening hours, in fact that patients were being failed. An 84 per cent overall satisfaction rate hardly supports those claims.

How officials will square the warnings with the facts will require some world-class rhetorical agility, especially as the DoH is to continue to push for extended opening hours. A 4 per cent demand for evening surgeries and 7 per cent for weekend surgeries is likely to strengthen the BMA's hand at the negotiating table.

This whole process has been another costly example of the DoH's obsession with the idea that GPs are in some way bad doctors. Officials' refusal to believe that GPs could score highly in the quality framework disrupted DoH budgets - now it has spent some £11 million on another wild goose chase. Hardly good for patient services - the same £11 million could have come in very handy for the seriously underfunded Hib jab catch-up plan or treating AMD patients, for example.

There are many problems within the NHS but it seems the DoH cannot get past the idea of the 'bad GP'. This week's working hours figures will inevitably be spun to support this notion again, when all it does is distract from the more pressing issue of tackling real service gaps.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs

 

Job of the Week